rs78378222 |
chr17 |
7571752 |
0.00001 |
T |
G |
Skin cancer (cutaneous basal cell carcinoma) |
TP53 |
UTR-3 |
21946351
|
rs78378222 |
chr17 |
7571752 |
0.00016 |
T |
G |
Skin cancer (cutaneous basal cell carcinoma) |
TP53 |
UTR-3 |
21946351
|
rs78378222 |
chr17 |
7571752 |
2.2e-20 |
T |
G |
Skin cancer (cutaneous basal cell carcinoma) |
TP53 |
UTR-3 |
21946351
|
rs78378222 |
chr17 |
7571752 |
0.0000024 |
T |
G |
Skin cancer (cutaneous basal cell carcinoma) |
TP53 |
UTR-3 |
21946351
|
rs78378222 |
chr17 |
7571752 |
4e-22 |
T |
G |
Basal cell carcinoma |
TP53 |
UTR-3 |
24403052
|
rs12951053 |
chr17 |
7577407 |
0.000053 |
A |
C |
Hematology traits |
TP53 |
intron |
23303382
|
rs1625895 |
chr17 |
7578115 |
2e-21 |
T |
C |
Sex hormone-binding globulin levels |
TP53 |
intron |
22829776
|
rs1042522 |
chr17 |
7579472 |
1 |
G |
C |
Drug response to Fluorouracil |
TP53 |
missense |
18357466
|
rs1042522 |
chr17 |
7579472 |
1 |
G |
C |
Drug response to Cisplatin |
TP53 |
missense |
19786980
|
rs1042522 |
chr17 |
7579472 |
1 |
G |
C |
Drug response to Cyclophosphamide |
TP53 |
missense |
19786980
|
rs8078476 |
chr17 |
7581228 |
0.000000294 |
G |
A |
HDL cholesterol |
TP53 |
intron |
23063622
|